Scarica l'app Stockscreener
6.55
2.24%
-0.15
Pre-mercato:
6.53
-0.02
-0.31%
Precedente Chiudi:
$6.70
Aprire:
$6.65
Volume 24 ore:
90,902
Relative Volume:
0.51
Capitalizzazione di mercato:
$373.01M
Reddito:
-
Utile/perdita netta:
$-66.86M
Rapporto P/E:
-5.4583
EPS:
-1.2
Flusso di cassa netto:
$-58.82M
1 W Prestazione:
-6.03%
1M Prestazione:
+7.20%
6M Prestazione:
+40.86%
1 anno Prestazione:
+25.96%
Intervallo 1D:
$6.315
$6.70
Intervallo di 1 settimana:
$6.25
$7.0592
Portata 52W:
$2.60
$7.77
Design Therapeutics Inc Stock (DSGN) Company Profile
Nome
Design Therapeutics Inc
Settore
Industria
Telefono
858-293-4900
Indirizzo
6005 HIDDEN VALLEY ROAD, CARLSBAD
Confronta DSGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DSGN
Design Therapeutics Inc
|
6.55 | 381.55M | 0 | -66.86M | -58.82M | -1.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Design Therapeutics Inc Stock (DSGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-05-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-11-14 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-08-15 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-08-15 | Downgrade | SVB Securities | Outperform → Market Perform |
| 2023-08-15 | Downgrade | Wedbush | Outperform → Neutral |
| 2023-05-04 | Aggiornamento | Goldman | Sell → Neutral |
| 2022-06-10 | Iniziato | Wedbush | Outperform |
| 2022-05-02 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-01-19 | Iniziato | Goldman | Sell |
| 2021-04-20 | Iniziato | Goldman | Neutral |
| 2021-04-20 | Iniziato | Piper Sandler | Overweight |
| 2021-04-20 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Design Therapeutics Inc Borsa (DSGN) Ultime notizie
Why retail investors favor Design Therapeutics Inc. stockStock Surge & Safe Swing Trade Setups - newser.com
What indicators show strength in Design Therapeutics Inc.Market Growth Summary & Real-Time Sentiment Analysis - newser.com
Analyzing Design Therapeutics Inc. with risk reward ratio charts2025 Winners & Losers & Low Risk Entry Point Guides - newser.com
Technical signs of recovery in Design Therapeutics Inc.2025 Market Overview & Accurate Buy Signal Alerts - newser.com
Design Therapeutics Inc expected to post a loss of 34 cents a shareEarnings Preview - TradingView
Is Design Therapeutics Inc. stock poised for growthTrade Entry Summary & Verified Short-Term Trading Plans - newser.com
How to interpret RSI for Design Therapeutics Inc. stockJuly 2025 Outlook & Weekly Return Optimization Alerts - newser.com
How to integrate Design Therapeutics Inc. into portfolio analysis toolsTrade Risk Assessment & Smart Allocation Stock Tips - newser.com
Developing predictive dashboards with Design Therapeutics Inc. dataPortfolio Growth Summary & Weekly Top Gainers Alerts - newser.com
Design Therapeutics (NASDAQ:DSGN) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Regression analysis insights on Design Therapeutics Inc. performanceJobs Report & High Win Rate Trade Alerts - newser.com
How to recover losses in Design Therapeutics Inc. stockWeekly Trade Report & Weekly Sector Rotation Insights - newser.com
Design Therapeutics, Inc. (NASDAQ:DSGN) Short Interest Update - MarketBeat
What recovery options are there for Design Therapeutics Inc.July 2025 Review & Free Technical Pattern Based Buy Signals - newser.com
Design Therapeutics (DSGN) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Should you wait for a breakout in Design Therapeutics Inc.Market Risk Summary & Safe Capital Growth Trade Ideas - newser.com
Published on: 2025-10-31 05:37:27 - newser.com
Published on: 2025-10-31 00:22:12 - newser.com
Published on: 2025-10-31 00:00:29 - newser.com
Published on: 2025-10-29 02:11:27 - newser.com
Forecasting Design Therapeutics Inc. price range with options data2025 Top Gainers & Daily Chart Pattern Signal Reports - newser.com
How buybacks impact Design Therapeutics Inc. stock valueJuly 2025 Highlights & Entry and Exit Point Strategies - fcp.pa.gov.br
Design Therapeutics Advances DT-168 Study for Fuchs Dystrophy - TipRanks
Design Therapeutics Advances DT-216P2 Study for Friedreich’s Ataxia - TipRanks
Design Therapeutics Advances with New Study on DT-216P2 for Friedreich Ataxia - TipRanks
Design Therapeutics Inc Azioni (DSGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.64%
0.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):